These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 9688880)

  • 1. A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake.
    Galassetti P; Shiota M; Zinker BA; Wasserman DH; Cherrington AD
    Am J Physiol; 1998 Jul; 275(1):E101-11. PubMed ID: 9688880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A negative arterial-portal venous glucose gradient increases net hepatic glucose uptake in euglycemic dogs.
    Galassetti P; Chu CA; Neal DW; Reed GW; Wasserman DH; Cherrington AD
    Am J Physiol; 1999 Jul; 277(1):E126-34. PubMed ID: 10409136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of a negative arterial-portal venous glucose gradient in the postexercise state.
    Galassetti P; Koyama Y; Coker RH; Lacy DB; Cherrington AD; Wasserman DH
    Am J Physiol; 1999 Dec; 277(6):E1038-45. PubMed ID: 10600793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of the hepatic arterial glucose level in generation of the portal signal in conscious dogs.
    Hsieh PS; Moore MC; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E284-92. PubMed ID: 10913027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal.
    Dicostanzo CA; Dardevet DP; Neal DW; Lautz M; Allen E; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E9-E16. PubMed ID: 16105863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnitude of negative arterial-portal glucose gradient alters net hepatic glucose balance in conscious dogs.
    Pagliassotti MJ; Myers SR; Moore MC; Neal DW; Cherrington AD
    Diabetes; 1991 Dec; 40(12):1659-68. PubMed ID: 1684554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
    Shiota M; Galassetti P; Monohan M; Neal DW; Cherrington AD
    Diabetes; 1998 Jun; 47(6):867-73. PubMed ID: 9604861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both positive and negative portal venous and hepatic arterial glucose gradients stimulate hepatic glucose uptake after the same amount of glucose is infused into the splanchnic bed in conscious dogs.
    Horikawa S; Ishida T; Igawa K; Kawanishi K; Hartley CJ; Takahara J
    Metabolism; 1998 Nov; 47(11):1295-302. PubMed ID: 9826203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of atropine and gastric inhibitory polypeptide on hepatic glucose uptake and insulin extraction in conscious dogs.
    Chap Z; Ishida T; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1985 Sep; 76(3):1174-81. PubMed ID: 3900134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
    Nishizawa M; Moore MC; Shiota M; Gustavson SM; Snead WL; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1027-36. PubMed ID: 12569088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs.
    Moore MC; DiCostanzo CA; Dardevet D; Lautz M; Farmer B; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E556-63. PubMed ID: 15522992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems.
    Matsuhisa M; Morishima T; Nakahara I; Tomita T; Shiba Y; Kubota M; Wada M; Kanda T; Kubota M; Kawamori R; Yamasaki Y
    Diabetes; 1997 Jul; 46(7):1101-5. PubMed ID: 9200642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.
    Moore MC; Kimura K; Shibata H; Honjoh T; Saito M; Everett CA; Smith MS; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E225-31. PubMed ID: 15755767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.
    Sindelar DK; Balcom JH; Chu CA; Neal DW; Cherrington AD
    Diabetes; 1996 Nov; 45(11):1594-604. PubMed ID: 8866566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraportal administration of neuropeptide Y and hepatic glucose metabolism.
    Nishizawa M; Shiota M; Moore MC; Gustavson SM; Neal DW; Cherrington AD
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1197-204. PubMed ID: 18234742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior exercise increases net hepatic glucose uptake during a glucose load.
    Galassetti P; Coker RH; Lacy DB; Cherrington AD; Wasserman DH
    Am J Physiol; 1999 Jun; 276(6):E1022-9. PubMed ID: 10362614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic glucose uptake rapidly decreases after removal of the portal signal in conscious dogs.
    Hsieh PS; Moore MC; Neal DW; Cherrington AD
    Am J Physiol; 1998 Dec; 275(6):E987-92. PubMed ID: 9843741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic and muscle glucose metabolism during total parenteral nutrition: impact of infection.
    McGuinness OP; Donmoyer C; Ejiofor J; McElligott S; Lacy DB
    Am J Physiol; 1998 Nov; 275(5):E763-9. PubMed ID: 9814994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal venous 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output.
    Camacho RC; Pencek RR; Lacy DB; James FD; Donahue EP; Wasserman DH
    Diabetes; 2005 Feb; 54(2):373-82. PubMed ID: 15677495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.